Intra-articular vs. intravenous administration: a meta-analysis of tranexamic acid in primary total knee arthroplasty
- PMID: 33267906
- PMCID: PMC7709322
- DOI: 10.1186/s13018-020-02119-1
Intra-articular vs. intravenous administration: a meta-analysis of tranexamic acid in primary total knee arthroplasty
Abstract
Background: The optimal dosage and administration approach of tranexamic acid (TXA) in primary total knee arthroplasty (TKA) remains controversial. In light of recently published 14 randomized controlled trials (RCTs), the study aims to incorporate the newly found evidence and compare the efficacy and safety of intra-articular (IA) vs. intravenous (IV) application of TXA in primary TKA.
Methods: PubMed, Embase, Web of Science, and Cochrane Library were searched for RCTs comparing IA with IV TXA for primary TKA. Primary outcomes included total blood loss (TBL) and drain output. Secondary outcomes included hidden blood loss (HBL), hemoglobin (Hb) fall, blood transfusion rate, perioperative complications, length of hospital stay, and tourniquet time.
Result: In all, 34 RCTs involving 3867 patients were included in our meta-analysis. Significant advantages of IA were shown on TBL (MD = 33.38, 95% CI = 19.24 to 47.51, P < 0.001), drain output (MD = 28.44, 95% CI = 2.61 to 54.27, P = 0.03), and postoperative day (POD) 3+ Hb fall (MD = 0.24, 95% CI = 0.09 to 0.39, P = 0.001) compared with IV. There existed no significant difference on HBL, POD1 and POD2 Hb fall, blood transfusion rate, perioperative complications, length of hospital stay, and tourniquet time between IA and IV.
Conclusion: Intra-articular administration of TXA is superior to intravenous in primary TKA patients regarding the performance on TBL, drain output, and POD3+ Hb fall, without increased risk of perioperative complications. Therefore, intra-articular administration is the recommended approach in clinical practice for primary TKA.
Keywords: Intra-articular administration; Intravenous administration; Total knee arthroplasty; Tranexamic acid.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Intra-articular versus intravenous tranexamic acid application in total knee arthroplasty: a meta-analysis of randomized controlled trials.Arch Orthop Trauma Surg. 2017 Jul;137(7):997-1009. doi: 10.1007/s00402-017-2683-1. Epub 2017 Apr 4. Arch Orthop Trauma Surg. 2017. PMID: 28378211 Review.
-
Combined intravenous and intra-articular tranexamic acid administration in total knee arthroplasty for preventing blood loss and hyperfibrinolysis: A randomized controlled trial.Medicine (Baltimore). 2019 Feb;98(7):e14458. doi: 10.1097/MD.0000000000014458. Medicine (Baltimore). 2019. PMID: 30762760 Free PMC article. Clinical Trial.
-
Effect of Multiple Doses of Intravenous Tranexamic Acid on Perioperative Blood Loss in Total Knee Arthroplasty: A Randomized Controlled Study.Orthop Surg. 2021 Feb;13(1):126-133. doi: 10.1111/os.12850. Epub 2020 Dec 8. Orthop Surg. 2021. PMID: 33295133 Free PMC article. Clinical Trial.
-
Comparison of oral versus intra-articular tranexamic acid in enhanced-recovery primary total knee arthroplasty without tourniquet application: a randomized controlled trial.BMC Musculoskelet Disord. 2018 Mar 15;19(1):85. doi: 10.1186/s12891-018-1996-8. BMC Musculoskelet Disord. 2018. PMID: 29544472 Free PMC article. Clinical Trial.
-
The efficacy and safety of combined administration of intravenous and topical tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled trials.BMC Musculoskelet Disord. 2018 Sep 7;19(1):321. doi: 10.1186/s12891-018-2181-9. BMC Musculoskelet Disord. 2018. PMID: 30193586 Free PMC article. Review.
Cited by
-
Does Tranexamic Acid Reduce the Blood Loss in Various Surgeries? An Umbrella Review of State-of-the-Art Meta-Analysis.Front Pharmacol. 2022 May 19;13:887386. doi: 10.3389/fphar.2022.887386. eCollection 2022. Front Pharmacol. 2022. PMID: 35662737 Free PMC article. Review.
-
Population Pharmacokinetics of Intra-articular and Intravenous Administration of Tranexamic Acid in Patients Undergoing Total Knee Replacement.Clin Pharmacokinet. 2022 Jan;61(1):83-95. doi: 10.1007/s40262-021-01043-9. Epub 2021 Jul 13. Clin Pharmacokinet. 2022. PMID: 34255299
-
The Effect of Intravenous Tranexamic Acid on Perioperative Blood Loss, Transfusion Requirements, Verticalization, and Ambulation in Total Knee Arthroplasty: A Randomized Double-Blind Study.Medicina (Kaunas). 2024 Jul 21;60(7):1183. doi: 10.3390/medicina60071183. Medicina (Kaunas). 2024. PMID: 39064612 Free PMC article. Clinical Trial.
-
Effects of Pre-Donated Autologous Blood Transfusion on Peri-Operative Hemoglobin Concentration and Mid-Term Health Outcomes in Primary Total Knee Arthroplasty.J Clin Med. 2022 Apr 18;11(8):2252. doi: 10.3390/jcm11082252. J Clin Med. 2022. PMID: 35456344 Free PMC article.
-
The necessity of suction drainage when intra-articular injection of tranexamic acid is used during primary total knee arthroplasty: a retrospective study.BMC Musculoskelet Disord. 2024 Jun 18;25(1):475. doi: 10.1186/s12891-024-07604-w. BMC Musculoskelet Disord. 2024. PMID: 38890633 Free PMC article.
References
-
- Fillingham YA, Ramkumar DB, Jevsevar DS, et al. Tranexamic acid use in total joint arthroplasty: the clinical practice guidelines endorsed by the American Association of Hip and Knee Surgeons, American Society of Regional Anesthesia and Pain Medicine, American Academy of Orthopaedic Surgeons, Hip Society, and Knee Society. J Arthroplasty. 2018;33(10):3065–3069. doi: 10.1016/j.arth.2018.08.002. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials